Posted On: 03/09/2016 12:57:37 PM
Post# of 72446
How can they get away with making these claims? Kevetrin is and has been in a "clinical trial" for 3 years. It's been presented at ASCO twice! Perhaps someone should send Leo an email to clue him in. These people need to be put on notice...
http://www.businesswire.com/news/home/2016030...Closes-EUR
Quote:
If you read about apr-246 - you see mention in various articles
"lead program APR-246, a first-in-class anticancer compound reactivating the tumor suppressor protein p53". OR "the only drug in clinical trial targeting p53" - Amatuer17
http://www.businesswire.com/news/home/2016030...Closes-EUR
(0)
(0)
